On October 30, the World Health Organization (WHO) formally awarded Barbados a landmark public health distinction, confirming that the Caribbean island nation has eliminated mother-to-child transmission (MTCT) of HIV, bringing the vertical spread of the virus down to levels no longer classified as a public health concern. The announcement, made public on October 31, marks Barbados as a global demonstration of what targeted, equitable maternal health interventions can achieve: between 2022 and 2024, zero new pediatric HIV cases linked to vertical transmission were recorded among infants born in the country, with 98% of all pregnant people accessing prenatal care, 98% receiving routine HIV testing, and 98% of pregnant people living with HIV being prescribed life-saving antiretroviral therapy. These medications suppress viral load, drastically cutting the risk of passing HIV to a child during pregnancy, labor, or delivery.
The WHO emphasized that Barbados’ breakthrough was decades in the making, built on sustained public investments that guarantee free, unrestricted HIV testing and treatment for all pregnant women regardless of nationality, alongside formal protections for patient privacy and human rights. The achievement places Barbados among a growing cohort of 15 countries and territories across North, Central, South America, and the Caribbean that have secured WHO validation for eliminating MTCT of HIV, syphilis, or hepatitis B, or meeting critical intermediate benchmarks toward those goals. Globally, 26 jurisdictions now hold such formal recognition, though the WHO notes these certifications apply to specific disease targets and do not universally confirm full elimination of all three vertical transmission pathways across every recognized nation.
The Caribbean region has seen a wave of parallel progress in recent years: the Bahamas and the Turks and Caicos Islands earned WHO validation for eliminating MTCT of HIV in 2026, while Brazil hit the same milestone in 2025. Jamaica, Saint Vincent and the Grenadines, and Belize had previously received recognition for eradicating combined MTCT of HIV and syphilis. Regional health leaders stress that these collective wins prove universal, timely access to prenatal screening, treatment, and clinical support can drastically reduce preventable pediatric illness.
Neighboring Suriname is actively working toward the same WHO MTCT elimination certification, with a 2023 study published in the Pan American Journal of Public Health documenting both notable progress and remaining gaps in local care systems. The research analyzed data from 279 mothers living with HIV and their 317 children born between 2016 and 2018, finding that 89.3% of recorded cases saw no HIV transmission from mother to child, 84.2% of pregnant women with HIV accessed antiretroviral treatment, and 95.5% of infants exposed to HIV in utero received recommended post-exposure prophylactic medication. However, the study also flagged critical systemic shortfalls: only 71.5% of participating women received an HIV test during pregnancy, 15% never accessed any prenatal care at all, and 8% gave birth outside of formal health facilities. Researchers highlighted that rural, inland communities face particularly steep barriers to accessing consistent maternal care, making early prenatal outreach a top priority.
To close these gaps, Suriname has rolled out targeted new public health supports in partnership with the Pan American Health Organization (PAHO), WHO’s regional arm for the Americas. In May 2026, PAHO donated 334 vials of benzathine benzylpenicillin, a first-line antibiotic for syphilis treatment, to Suriname’s Regional Health Service (RGD) and Medical Mission, the two primary providers of frontline community care. The donation is designed to speed up syphilis treatment for pregnant women and reduce associated pregnancy and birth complications. Then in July 2026, PAHO delivered 22 dual HIV and syphilis rapid test kits and five laboratory microscopes to the Medical Mission, to expand screening capacity and diagnostic capabilities in remote inland communities. These interventions form part of a national, regional push to eliminate vertical transmission of HIV, syphilis, and hepatitis B across the country.
Health officials note that WHO’s formal elimination certification requires far more than a temporary stretch of zero new MTCT cases: countries must also prove their health systems meet international standards for testing coverage, continuous treatment access, long-term patient monitoring, and protection of maternal human rights. Barbados’ success now serves as a actionable blueprint for the rest of the Caribbean, while Suriname continues to scale up its outreach, supply chain, and care infrastructure to reach the same life-saving milestone for its own population.
Barbados bereikt belangrijke mijlpaal in strijd tegen hiv
